
Some promising news coming from the Moderna vaccine trial.
Researchers say it appears to create a strong immune response in older people, as well as younger adults.
Some promising news coming from the Moderna vaccine trial.
Researchers say it appears to create a strong immune response in older people, as well as younger adults.
RESEARCHERS SAY IT APPEARS TOCREATE A STRONG IMMUNE RESPONSEIN OLDER PEOPLE - - AS WELL ASYOUNGER ADULTS.PREVIOUSLY - THE NEW ENGLANDJOURNAL OF MEDICINE PUBLISHED ASMALL STUDY SAYING MANYVACCINES DON'T WORK AS WELL INTHE ELDERLY.PEOPLE -50- TO -64- YEARS OLDARE MORE LIKELY TO BEHOSPITALIZED AND DIE FROMCOVID-19.THE U-S SENA
*SHELTON, CT / ACCESSWIRE / **January 27, 2021 /* NanoViricides, Inc. (NYSE American: NNVC) (the "Company") a global leader in the..
A local clinic is in the final stages of testing a different Covid-19 vaccine, that won't require the low termperature storage.